• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物医学应用的脂质纳米囊泡:“名称中有何含义”?

Lipid nanovesicles for biomedical applications: 'What is in a name'?

机构信息

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil.

Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil; Institute of Molecular Microbiology and Biotechnology, University of Münster, Germany.

出版信息

Prog Lipid Res. 2021 Apr;82:101096. doi: 10.1016/j.plipres.2021.101096. Epub 2021 Apr 5.

DOI:10.1016/j.plipres.2021.101096
PMID:33831455
Abstract

Vesicles, generally defined as self-assembled structures formed by single or multiple concentric bilayers that surround an aqueous core, have been widely used for biomedical applications. They can either occur naturally (e.g. exosomes) or be produced artificially and range from the micrometric scale to the nanoscale. One the most well-known vesicle is the liposome, largely employed as a drug delivery nanocarrier. Liposomes have been modified along the years to improve physicochemical and biological features, resulting in long-circulating, ligand-targeted and stimuli-responsive liposomes, among others. In this process, new nomenclatures were reported in an extensive literature. In many instances, the new names suggest the emergence of a new nanocarrier, which have caused confusion as to whether the vesicles are indeed new entities or could simply be considered modified liposomes. Herein, we discussed the extensive nomenclature of vesicles based on the suffix "some" that are employed for drug delivery and composed of various types and proportions of lipids and others amphiphilic compounds. New names have most often been selected based on changes of vesicle lipid composition, but the payload, structural complexity (e.g. multicompartment) and new/improved proprieties (e.g. elasticity) have also inspired new vesicle names. Based on this discussion, we suggested a rational classification for vesicles.

摘要

囊泡通常被定义为由单层或多层同心双层膜围绕水核自组装形成的结构,已广泛应用于生物医学领域。它们可以是天然存在的(例如外泌体),也可以是人工合成的,尺寸范围从微米到纳米。最著名的囊泡之一是脂质体,它主要用作药物递送纳米载体。多年来,脂质体经过修饰以改善物理化学和生物学特性,产生了长循环、配体靶向和刺激响应的脂质体等。在这个过程中,大量文献报道了新的命名法。在许多情况下,新名称表明出现了新的纳米载体,这导致了人们的困惑,即这些囊泡是否确实是新的实体,或者它们是否可以简单地被认为是修饰的脂质体。在此,我们根据后缀“some”讨论了广泛用于药物递送的囊泡命名法,这些囊泡由各种类型和比例的脂质和其他两亲性化合物组成。新名称的选择通常基于囊泡脂质组成的变化,但有效载荷、结构复杂性(例如多隔室)和新/改进的特性(例如弹性)也启发了新的囊泡名称。基于此讨论,我们提出了一种基于后缀“some”的囊泡分类法。

相似文献

1
Lipid nanovesicles for biomedical applications: 'What is in a name'?用于生物医学应用的脂质纳米囊泡:“名称中有何含义”?
Prog Lipid Res. 2021 Apr;82:101096. doi: 10.1016/j.plipres.2021.101096. Epub 2021 Apr 5.
2
Construction of nanoscale multicompartment liposomes for combinatory drug delivery.用于联合给药的纳米级多隔室脂质体的构建
Int J Pharm. 2007 Mar 1;331(2):182-5. doi: 10.1016/j.ijpharm.2006.11.020. Epub 2006 Nov 11.
3
Liposomes as biocompatible and smart delivery systems - the current state.脂质体作为生物相容和智能递药系统——现状。
Adv Colloid Interface Sci. 2022 Nov;309:102757. doi: 10.1016/j.cis.2022.102757. Epub 2022 Aug 19.
4
Constant pressure-controlled extrusion method for the preparation of Nano-sized lipid vesicles.用于制备纳米级脂质体的恒压控制挤压法。
J Vis Exp. 2012 Jun 22(64):4151. doi: 10.3791/4151.
5
Hydrophobe Containing Polypeptoids Complex with Lipids and Induce Fusogenesis of Lipid Vesicles.含疏水性聚肽模拟物与脂质形成复合物并诱导脂质囊泡融合。
J Phys Chem B. 2021 Apr 1;125(12):3145-3152. doi: 10.1021/acs.jpcb.0c11477. Epub 2021 Mar 17.
6
Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties.磷脂囊泡用于活性分子的经皮/透皮和鼻内给药:表面活性剂和醇对其脂质双层流动性和渗透增强特性的影响。
Molecules. 2020 Jun 27;25(13):2959. doi: 10.3390/molecules25132959.
7
Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes.脂质体、外泌体和杂交外泌体:癌症治疗的脂质载体的进展。
Cancer Lett. 2023 Jul 1;565:216220. doi: 10.1016/j.canlet.2023.216220. Epub 2023 May 19.
8
Design of liposomes as drug delivery system for therapeutic applications.脂质体作为治疗应用的药物传递系统的设计。
Int J Pharm. 2021 May 15;601:120571. doi: 10.1016/j.ijpharm.2021.120571. Epub 2021 Apr 2.
9
Methyl-Branched Liposomes as a Depot for Sustained Drug Delivery.甲基分支脂质体作为一种药物持续递送的储库。
Nano Lett. 2023 Oct 25;23(20):9250-9256. doi: 10.1021/acs.nanolett.3c02137. Epub 2023 Oct 3.
10
Stimuli-responsive phospholipid-drug conjugates (PDCs)-based nanovesicles for drug delivery and theranostics.基于刺激响应性磷脂-药物偶联物(PDCs)的纳米囊泡用于药物递送和治疗诊断一体化。
Int J Pharm. 2020 Nov 30;590:119920. doi: 10.1016/j.ijpharm.2020.119920. Epub 2020 Sep 28.

引用本文的文献

1
Dipalmitoylphosphatidylcholine Lipid Vesicles for Delivering HMB, NMN, and L-Leucine in Sarcopenia Therapy.用于肌肉减少症治疗中递送HMB、NMN和L-亮氨酸的二棕榈酰磷脂酰胆碱脂质囊泡
Molecules. 2025 Mar 24;30(7):1437. doi: 10.3390/molecules30071437.
2
Photodynamic therapy for the precise treatment of localized prostate cancer.用于局部前列腺癌精准治疗的光动力疗法。
Front Oncol. 2025 Feb 5;15:1454392. doi: 10.3389/fonc.2025.1454392. eCollection 2025.
3
Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery.
超越皮肤的局限:基于磷脂的纳米囊泡在经皮药物传递中的变革作用。
AAPS PharmSciTech. 2024 Aug 13;25(6):184. doi: 10.1208/s12249-024-02896-6.
4
Customizable Microfluidic Devices: Progress, Constraints, and Future Advances.定制化微流控器件:进展、限制与未来进展。
Curr Drug Deliv. 2024;21(10):1285-1299. doi: 10.2174/0115672018264064231017113813.
5
Rational design of lipid nanoparticles: overcoming physiological barriers for selective intracellular mRNA delivery.脂质纳米粒的合理设计:克服选择性细胞内 mRNA 递释的生理屏障。
Curr Opin Chem Biol. 2024 Aug;81:102499. doi: 10.1016/j.cbpa.2024.102499. Epub 2024 Jul 13.
6
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications.纳米药物在前列腺癌治疗中的新兴趋势:观点与潜在应用
Pharmaceutics. 2024 Feb 20;16(3):297. doi: 10.3390/pharmaceutics16030297.
7
Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications.功能性脂质纳米颗粒的进展:从药物递送平台到临床应用
3 Biotech. 2024 Feb;14(2):57. doi: 10.1007/s13205-023-03901-8. Epub 2024 Jan 29.
8
Enhancing Gene Therapy through Ultradeformable Vesicles for Efficient siRNA Delivery.通过超可变形囊泡增强基因治疗以实现高效的小干扰RNA递送
Pharm Nanotechnol. 2025;13(1):55-69. doi: 10.2174/0122117385271654231215064542.
9
Progress in oncolytic viruses modified with nanomaterials for intravenous application.纳米材料修饰的溶瘤病毒在静脉给药方面的研究进展。
Cancer Biol Med. 2023 Nov 24;20(11):830-55. doi: 10.20892/j.issn.2095-3941.2023.0275.
10
Exploring Applications of Flexible Vesicular Systems as Transdermal Drug Delivery.探索柔性囊泡系统在经皮给药中的应用。
Curr Drug Deliv. 2024;21(8):1062-1072. doi: 10.2174/1567201821666230830125253.